» Authors » Robel Yirgu

Robel Yirgu

Explore the profile of Robel Yirgu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 242
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hounsome N, Yirgu R, Middleton J, Cassell J, Fekadu A, Davey G
Front Health Serv . 2024 Oct; 4:1279762. PMID: 39359345
Background: The strategies to control scabies in highly endemic populations include individual case/household management and mass drug administration (MDA). We used a decision-analytic model to compare ivermectin-based MDA and individual...
2.
Yirgu R, Middleton J, Cassell J, Bremner S, Davey G, Fekadu A
PLoS Negl Trop Dis . 2024 Aug; 18(8):e0012429. PMID: 39163473
Introduction: Scabies undermines quality of life through its highly disturbing disease symptoms, by distorting self-perception, and secondary to social stigma. Knowledge of its effect on quality of life in general...
3.
Shiferaw R, Yirgu R, Getnet Y
BMC Pediatr . 2024 Mar; 24(1):216. PMID: 38532394
Background: A Suitable environment and proper child nutrition are paramount to a child's physical and mental development. Different environmental factors contribute to proper child development. Breast milk is an important...
4.
Yirgu R, Middleton J, Fekadu A, Cassell J, Tesfaye A, Jones C, et al.
BMJ Open . 2023 Oct; 13(10):e075038. PMID: 37880172
Background: The WHO aims to prevent, eliminate or control neglected tropical diseases, including scabies, by 2030. However, limited epidemiological data presented a challenge to control efforts, especially in high burden...
5.
Yirgu R, Middleton J, Fekadu A, Davey G, Bremner S, Jones C, et al.
Trans R Soc Trop Med Hyg . 2023 Sep; 118(2):110-117. PMID: 37665766
Background: Mass drug administration (MDA) is among the five major strategies that are currently in use to control, eliminate or eradicate Neglected Tropical Diseases (NTDs). Optimising MDA to control multiple...
6.
Yirgu R, Wondimagegnehu A, Qian J, Milkovich R, Zimmerman L, Decker M, et al.
BMC Public Health . 2023 Apr; 23(1):725. PMID: 37081421
Background: Globally, 2-14% of women experience intimate partner violence (IPV) during pregnancy. Timely response to IPV is critical to mitigate related adverse health outcomes. Barriers to accessing limited IPV support...
7.
Wood S, Dozier J, Karp C, Desta S, Decker M, Shiferaw S, et al.
Sex Reprod Health Matters . 2022 Dec; 30(1):2139891. PMID: 36469634
Partner-perpetrated pregnancy coercion inhibits women's reproductive autonomy. However, few studies have quantified pregnancy coercion and its effects on women's health within low- and middle-income countries. Among a national sample of...
8.
Wood S, Yirgu R, Karp C, Tadesse M, Shiferaw S, Zimmerman L
EClinicalMedicine . 2022 Nov; 53:101715. PMID: 36345400
Background: Gendered health inequities impede women's reproductive autonomy over the life course. Pregnancy is a critical time point for assessing inequities and partners are integral actors in the achievement or...
9.
Dozier J, Zimmerman L, Ejigu B, Shiferaw S, Seme A, Yihdego M, et al.
Contracept X . 2022 Oct; 4:100084. PMID: 36193281
Objective: To examine the relationship between pregnancy coercion and partner knowledge of contraceptive use. Study Design: Cross-sectional Performance Monitoring for Action-Ethiopia data were collected in October-November 2019 from a nationally...
10.
Wood S, Yirgu R, Wondimagegnehu A, Qian J, Milkovich R, Decker M, et al.
BMJ Open . 2022 Apr; 12(4):e055790. PMID: 35414554
Objectives: This multimethods study aimed to: (1) compare the prevalence of intimate partner violence (IPV) during pregnancy pre-COVID-19 and during the COVID-19 pandemic using quantitative data and (2) contextualise pregnant...